Insight into the inhibitor discrimination by FLT3 F691L-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Insight into the inhibitor discrimination by FLT3 F691L

Published:2018-02-12 Issue:5 Volume:91 Page:1056-1064
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Verma Sharad¹,Singh Aditi¹²,Kumari Anchala¹²,Pandey Bharati³,Jamal Salma¹⁴,Goyal Sukriti¹⁴,Sinha Siddharth²,Grover Abhinav¹^ORCID

Affiliation:

1. School of Biotechnology; Jawaharlal Nehru University; New Delhi India

2. Department of Biotechnology; TERI School of Advanced Studies; New Delhi India

3. Department of Biotechnology; Panjab University; Chandigarh India

4. Department of Bioscience and Biotechnology; Banasthali University; Tonk Rajasthan India

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.13169/fullpdf

Reference35 articles.

1. Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification

2. The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond

3. Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Status

4. Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 “Gatekeeper” F691L Mutation with PLX3397

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy;Critical Reviews in Oncology/Hematology;2024-09

2. Comparative transcriptomic and proteomic analysis of the antibacterial activity of emodin on Aeromonas hydrophila;Aquaculture;2020-12

3. Insights Into the Resistance Mechanisms of Inhibitors to FLT3 F691L Mutation via an Integrated Computational Approach;Frontiers in Pharmacology;2019-09-20

4.

Quizartinib (AC220): a promising option for acute myeloid leukemia

;Drug Design, Development and Therapy;2019-04

5. Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance;International Journal of Molecular Sciences;2018-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3